<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001973'>Idiopathic thrombocytopenic purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>) is a common <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> in patients with common variable <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVID</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a 36-year-old woman with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVID</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical course of <z:e sem="disease" ids="C0017925" disease_type="Disease or Syndrome" abbrv="">her disease</z:e> was complicated by <z:hpo ids='HP_0002110'>bronchiectasis</z:hpo>, <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, and portal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>She developed recurrent attacks of <z:chebi fb="0" ids="16039">ITP</z:chebi> refractory to high doses of <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, intravenous immunoglobulin (IVIG), and splenectomy </plain></SENT>
<SENT sid="4" pm="."><plain>She received a total of 5 doses of rituximab (375 mg/m2) and achieved an immediate and persistent response </plain></SENT>
<SENT sid="5" pm="."><plain>Therapy was well tolerated </plain></SENT>
<SENT sid="6" pm="."><plain>Her platelet count remained above 370,000/microL for 8 months of follow-up, despite repeated <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>During this period the patient remained off <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and on continuous IVIG replacement therapy </plain></SENT>
</text></document>